ES8300747A1 - Procedimiento para la preparacion de derivados de acido in- dolacetico - Google Patents

Procedimiento para la preparacion de derivados de acido in- dolacetico

Info

Publication number
ES8300747A1
ES8300747A1 ES502848A ES502848A ES8300747A1 ES 8300747 A1 ES8300747 A1 ES 8300747A1 ES 502848 A ES502848 A ES 502848A ES 502848 A ES502848 A ES 502848A ES 8300747 A1 ES8300747 A1 ES 8300747A1
Authority
ES
Spain
Prior art keywords
same
producing
pharmaceutical compositions
indol acetic
acetic derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES502848A
Other languages
English (en)
Other versions
ES502848A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A Natterman und Cie GmbH
Original Assignee
A Natterman und Cie GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A Natterman und Cie GmbH filed Critical A Natterman und Cie GmbH
Publication of ES8300747A1 publication Critical patent/ES8300747A1/es
Publication of ES502848A0 publication Critical patent/ES502848A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE ACIDO INDOLACETICO Y DE SUS SALES FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE X ES HIDROGENO, FLUOR, CLORO O ALCOHILO C <003> ; Y N VALE DE 0 A 3. CONSISTE EN LA REACCION DE UN COMPUESTO DE FORMULA (II), EN LA QUE X Y N SON LOS MISMOS QUE EN LA FORMULA (I), O UNA SAL ALCALINA DEL MISMO, CON ACIDO 1-(P-CLOROBENZOIL)-5-METOXI-2-METILINDOL-3-ACETICO, UN CLORURO O UN ALCOHILESTER C <003> DEL MISMO. LA REACCION SE EFECTUA EN UN DISOLVENTE ORGANICO INERTE EN PRESENCIA DE UNA CARBODIIMIDA Y DE TRIMETIALUMINIO. >ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS POR SU ACTIVIDAD ANTITROMBOTICA, ANTIARTERIOSCLEROTICA, ANALGESICA Y ANTIFLOGISTICA
ES502848A 1980-09-10 1981-06-08 Procedimiento para la preparacion de derivados de acido in- dolacetico Granted ES502848A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3034005A DE3034005C2 (de) 1980-09-10 1980-09-10 Indolessigsäure-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen

Publications (2)

Publication Number Publication Date
ES8300747A1 true ES8300747A1 (es) 1982-11-01
ES502848A0 ES502848A0 (es) 1982-11-01

Family

ID=6111558

Family Applications (1)

Application Number Title Priority Date Filing Date
ES502848A Granted ES502848A0 (es) 1980-09-10 1981-06-08 Procedimiento para la preparacion de derivados de acido in- dolacetico

Country Status (15)

Country Link
EP (1) EP0047358B1 (es)
JP (1) JPS5750988A (es)
AR (1) AR229470A1 (es)
AT (1) ATE9470T1 (es)
AU (1) AU539442B2 (es)
CA (1) CA1164862A (es)
DE (1) DE3034005C2 (es)
DK (1) DK236781A (es)
ES (1) ES502848A0 (es)
FI (1) FI68622C (es)
HU (1) HU187338B (es)
IE (1) IE51776B1 (es)
PT (1) PT73435B (es)
YU (1) YU135081A (es)
ZA (1) ZA813637B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3236243A1 (de) * 1982-09-30 1984-04-05 Merck Patent Gmbh, 6100 Darmstadt Schwefelhaltige indolderivate
DE60323130D1 (de) 2002-11-25 2008-10-02 Hoffmann La Roche Indolderivaten
CN104876848B (zh) * 2015-05-15 2017-05-17 南开大学 一种1‑酰基‑3‑吲哚硫酯化合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD70880A (es) *
US3966956A (en) * 1972-07-14 1976-06-29 Troponwerke Dinklage & Company [1-(P-Chlorobenzoyl)-5-methoxy-2-methyl-3-indole]acetoxyacetic acid and salts in treating inflammation
US4119638A (en) * 1976-11-29 1978-10-10 G. D. Searle & Co. Thio-ester of 1 (p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid
DE2735537A1 (de) * 1977-08-06 1979-02-22 Troponwerke Gmbh & Co Kg Indolacetoxyacetylaminosaeurederivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
EP0047358B1 (en) 1984-09-19
DK236781A (da) 1982-03-11
YU135081A (en) 1984-02-29
FI812418L (fi) 1982-03-11
JPS5750988A (en) 1982-03-25
AU539442B2 (en) 1984-09-27
HU187338B (en) 1985-12-28
FI68622B (fi) 1985-06-28
AU7265081A (en) 1982-03-18
FI68622C (fi) 1985-10-10
CA1164862A (en) 1984-04-03
DE3034005A1 (de) 1982-05-06
ATE9470T1 (de) 1984-10-15
PT73435B (en) 1982-10-08
PT73435A (en) 1981-08-01
DE3034005C2 (de) 1982-12-09
EP0047358A1 (en) 1982-03-17
IE811209L (en) 1982-03-10
ZA813637B (en) 1982-06-30
IE51776B1 (en) 1987-04-01
AR229470A1 (es) 1983-08-31
ES502848A0 (es) 1982-11-01

Similar Documents

Publication Publication Date Title
AU538424B2 (en) Piperazino phenylindane
CS782686A2 (en) Method of benzimidazole derivatives production
CA1258859A (en) CARBOSTYRILE DERIVATIVE, AND ITS PREPARATION
RU95112575A (ru) Соль арилпропионовой кислоты, способ ее получения и фармацевтическая композиция
FI854227A0 (fi) Menetelmä analgeettisena aineena käyttökelpoisten polypeptidien valmistamiseksi
IE811513L (en) Benzisoselenazolones
IE45439L (en) Penicillanic acid derivatives
ES8606282A1 (es) Un procedimiento de preparar derivados de acidos quinolin- ynaftiridin-carboxilicos
PT77370B (en) Process for preparing new pyrazolo &lt;3,4-b&gt; piridine derivatives and pharmaceutical preparations containing the same
AU557494B2 (en) 2-substituted-5-arylimidazoles
DE2963010D1 (en) 3-chloro-6-hydroxy-5-methylbenzoic acid derivatives, corresponding pharmaceutical preparations, growth promoting compositions, the use of the compounds for promoting growth in certain animals and their manufacture
ES8802612A1 (es) Procedimiento para preparar derivados de benzisoselenazolilo
IE811209L (en) Indole acetic acid derivatives
ES8604731A1 (es) Un metodo de preparar derivados de 6,11-dihidrodibenz (b,e) oxepina
AU7971182A (en) Anthranilic acid derivatives
ES8304924A1 (es) Un procedimiento para la preparacion de nuevos derivados del acido glutamil-diaminopimelico que contiene una b-lactama.
ATE10934T1 (de) Peptid, verfahren zu dessen herstellung und dessen verwendung.
ES8403458A1 (es) &#34;un procedimiento para la preparacion de nuevos derivados de tetrahidroquinolina&#34;.
JPS5246066A (en) Preparation of optically active 5-oxo-2-pyrrolipinyl acetic acid salts